Helen of Troy (NASDAQ:HELE) Issues Earnings Results, Beats Expectations By $0.09 EPS

Helen of Troy (NASDAQ:HELE - Get Free Report) released its earnings results on Thursday, April 23rd. The company reported $0.83 earnings per share for the quarter, beating the consensus estimate of $0.74 by $0.09, FiscalAI reports. The firm had revenue of $470.03 million for the quarter, compared to analyst estimates of $450.38 million. Helen of Troy had a positive return on equity of 7.00% and a negative net margin of 50.33%.The company's quarterly revenue was down 3.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.33 earnings per share. Helen of Troy updated its FY 2027 guidance to 3.250-3.750 EPS.

Here are the key takeaways from Helen of Troy's conference call:

• The company significantly mitigated tariff pain—turning a $51M gross tariff hit into a net operating income impact of less than $30M in FY26 and plans to reduce China‑tariff exposure to under 20% with dual‑sourcing rising to ~55% by end of FY27.
• Management laid out a three‑phase, multi‑year roadmap centered on consumer‑first innovation, digital/social commerce expansion, AI and advanced‑planning upgrades, and targeted brand investments to restore top‑line momentum.
• FY2027 guidance calls for net sales of $1.751B–$1.822B, adjusted EBITDA of $190M–$197M, adjusted EPS of $3.25–$3.75, and free cash flow of $85M–$100M, with first‑half EPS pressure from tariff COGS cycling and planned people/brand investments producing an uneven cadence.
• Balance sheet and cash actions are prioritized—FY26 free cash flow was $132M, the company paid down $112M of debt in the quarter and used ~$78M from a facility sale to reduce leverage, targeting ~3.2x net leverage or lower by year‑end FY27.

Helen of Troy Trading Up 1.7%

Shares of Helen of Troy stock opened at $24.36 on Wednesday. The stock has a market cap of $566.61 million, a P/E ratio of -0.62 and a beta of 1.29. The company has a quick ratio of 0.81, a current ratio of 1.71 and a debt-to-equity ratio of 0.95. Helen of Troy has a 12-month low of $13.85 and a 12-month high of $33.73. The business's 50 day moving average is $18.82 and its 200-day moving average is $18.96.

Institutional Trading of Helen of Troy

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD increased its stake in shares of Helen of Troy by 37.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 33,958 shares of the company's stock worth $722,000 after purchasing an additional 9,267 shares during the last quarter. Bridgefront Capital LLC acquired a new stake in shares of Helen of Troy in the fourth quarter valued at approximately $688,000. Boothbay Fund Management LLC boosted its stake in shares of Helen of Troy by 56.9% during the 4th quarter. Boothbay Fund Management LLC now owns 29,948 shares of the company's stock worth $636,000 after acquiring an additional 10,862 shares during the period. Man Group plc acquired a new position in shares of Helen of Troy during the 4th quarter worth approximately $528,000. Finally, BNP Paribas Financial Markets increased its holdings in shares of Helen of Troy by 54.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 16,775 shares of the company's stock worth $423,000 after acquiring an additional 5,942 shares during the last quarter.

Analyst Ratings Changes

HELE has been the subject of a number of recent research reports. Wall Street Zen raised Helen of Troy from a "hold" rating to a "buy" rating in a research report on Saturday, May 2nd. Weiss Ratings reissued a "sell (d-)" rating on shares of Helen of Troy in a research report on Friday, March 27th. UBS Group increased their target price on shares of Helen of Troy from $16.00 to $25.00 and gave the stock a "neutral" rating in a report on Friday, April 24th. Zacks Research raised shares of Helen of Troy from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, May 5th. Finally, Canaccord Genuity Group lifted their price target on shares of Helen of Troy from $18.00 to $23.00 and gave the company a "hold" rating in a research note on Friday, April 24th. Two research analysts have rated the stock with a Strong Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Helen of Troy presently has an average rating of "Moderate Buy" and an average target price of $24.00.

About Helen of Troy

Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.

The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.